Literature DB >> 89858

Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved.

J Shoham, M Cohen.   

Abstract

The relationship between carcinoembryonic antigen (CEA) and A antigenic determinants on the cell surface of colon-tumour cells was studied by the ADCC assay. Antiserum prepared in 2 rabbits to an undecapeptide analogous to the amino terminal of CEA(1-11) was found by us either to participate in (Rabbit 2) or specifically inhibit (Rabbit 1) ADCC. The binding spectra of these two antisera and of antiserum to the whole CEA molecule were similar. All of them react with A and non-A colon-tumour cells as well as red blood cells of Type A (RBC-A) and their activity was completely absorbed on RBC-A but not on B or O. O-type, ADCC-reactive human sera always react with A-type colon-tumour cells and RBC-A, and some of them with non-A colon-tumour cells also. The degree of inhibition of their reactivity by anti-CEA(1-11) R1 varied between sera, from none to almost a complete inhibition, and is not related to whether the serum is of cancer or non-cancer origin. Non-reactive O-type sera contain anti-A activity demonstrable by haemagglutination and immunofluorescence. However, they cannot participate in ADCC reaction nor inhibit it. The sera, which contain lymphocyte-dependent antibody to A-type colon-tumour cells, lysed RBC-A, without the addition of lymphocytes or complement, in an immunologically specific way. It is concluded that the reactivity seen in our ADCC system is related to a determinant common to A and CEA (and maybe to other normal cross-reacting antigens) which most probably resides in the amino terminal part of these molecules. This determinant elicits the production of lymphocyte-dependent antibodies in about 50% of people with blood group O. Thus, the amino terminal part of CEA is not a tumour-specific part of the CEA molecule. No specific anti-tumour activity was found in patients' serum by this method, and claims for its demonstration by other methods may well be related to the non-specific activity observed here.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89858      PMCID: PMC2010009          DOI: 10.1038/bjc.1979.172

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome.

Authors:  M E Costanza; V Pinn; R S Schwartz; L Nathanson
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

2.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

3.  Substances immunologically related to CEA.

Authors:  S von Kleist
Journal:  Ann Immunol (Paris)       Date:  1973-11

4.  The blood group A-like site on the carcinoembryonic antigen.

Authors:  J M Gold; P Gold
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte?

Authors:  A H Greenberg; L Shen; I M Roitt
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

Review 6.  Carcinoembryonic antigen (CEA): molecular biology and clinical significance.

Authors:  A Fuks; C Banjo; J Shuster; S O Freedman; P Gold
Journal:  Biochim Biophys Acta       Date:  1975-07-11

7.  Heterogeneity of the protein moiety of carcinoembryonic antigens.

Authors:  A C Wang; C Banjo; A Fuks; J Shuster; P Gold
Journal:  Immunol Commun       Date:  1976

8.  Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.

Authors:  R Arnon; M Bustin; E Calef; S Chaitchik; J Haimovich; N Novik; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

9.  A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity.

Authors:  P Halloran; V Schirrmacher; H Festenstein
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

10.  Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population study.

Authors:  J Shoham; M Cohen
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  1 in total

1.  Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population study.

Authors:  J Shoham; M Cohen
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.